ArticleFood science & nutrition2025
Acceptability of Novel Formulated Ready to Use Food for Management of Moderate Acute Malnutrition (MAM) in Children Aged 6-59 Months in Tanzania: A Facility-Based Acceptability Trial.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Black soldier fly larvae and cricket fortified crackers are a safe, nutritious, and acceptable snack for school children in Madagascar.Scientific reports · 2026Article
- Acceptability of Novel Formulated Ready to Use Food for Management of Moderate Acute Malnutrition (MAM) in Children Aged 6-59 Months in Tanzania: A Facility-Based Acceptability Trial.Food science & nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malnutrition contributes to nearly half of all deaths among children below 5 years of age; it is a significant burden of suboptimal development in children who survive. Novel Ready-to-Use Food Supplements (RUFs) have been developed to treat moderate acute malnutrition (MAM) in children aged 6-59 months in Tanzania. This study aimed to assess the acceptability of these new RUFs, which are made from locally sourced ingredients. A facility-based acceptability trial was conducted to evaluate the new RUF formulations for MAM management. A total of 317 children aged 6-59 months were systematically randomly sampled and enrolled. Paired preference tests comparing the two novel RUFs (RUF 1 and RUF 5) were performed in Temeke Municipality, Tanzania. For the preference tests, mothers or caregivers received one 100 g sachet of either RUF 1 or RUF 5 daily for 2 days. For the acceptability trial, one sachet was provided every other day for 2 days. Each child tasted one of the novel RUFs on each day. Both novel RUFs demonstrated high acceptability, with over 90% of children accepting them. The mean average rating for RUF 5 was significantly higher than for RUF 1 across all attributes (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.